| 09/08/2026 8:59 AM | Charles River Laboratories International (1100682) Subject FMR LLC (315066) Filed by | Form SCHEDULE 13G/A | |
| 08/20/2026 3:31 PM | Andrews Nancy C (1804999) Reporting Charles River Laboratories International (1100682) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/20/2026 3:33 PM | Charles River Laboratories International (1100682) Issuer Parisotto Shannon M (1952784) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/20/2026 3:37 PM | Charles River Laboratories International (1100682) Issuer Girshick Birgit (1732091) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/19/2026 3:15 PM | Charles River Laboratories International (1100682) Subject Parisotto Shannon M (1952784) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/18/2026 10:06 AM | Andrews Nancy C (1804999) Reporting Charles River Laboratories International (1100682) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/13/2026 3:34 PM | Charles River Laboratories International (1100682) Issuer Parisotto Shannon M (1952784) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/13/2026 1:19 PM | Charles River Laboratories International (1100682) Subject Invesco Ltd. (914208) Filed by | Form SCHEDULE 13G | |
| 08/11/2026 3:35 PM | Charles River Laboratories International (1100682) Issuer FOSTER JAMES C (1141722) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/11/2026 3:07 PM | Charles River Laboratories International (1100682) Subject Girshick Birgit (1732091) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/10/2026 3:40 PM | Charles River Laboratories International (1100682) Issuer Knell Michael Gunnar (1543779) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for CRL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Charles River Laboratories International and its competitors with MarketBeat's FREE daily newsletter.
|
| 08/10/2026 3:29 PM | Charles River Laboratories International (1100682) Subject FOSTER JAMES C (1141722) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/10/2026 3:35 PM | Charles River Laboratories International (1100682) Issuer Creamer Victoria L (1632780) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/06/2026 3:49 PM | Charles River Laboratories International (1100682) Issuer Parisotto Shannon M (1952784) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/06/2026 2:09 PM | Charles River Laboratories International (1100682) Subject Knell Michael Gunnar (1543779) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/06/2026 2:09 PM | Charles River Laboratories International (1100682) Subject Creamer Victoria L (1632780) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/06/2026 9:17 AM | Charles River Laboratories International (1100682) Subject FMR LLC (315066) Filed by | Form SCHEDULE 13G/A | |
| 08/05/2026 8:21 AM | Charles River Laboratories International (1100682) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/05/2026 6:15 AM | Charles River Laboratories International (1100682) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/01/2026 3:59 PM | Charles River Laboratories International (1100682) Issuer FOSTER JAMES C (1141722) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/29/2026 3:44 PM | Charles River Laboratories International (1100682) Subject FOSTER JAMES C (1141722) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/08/2026 3:19 PM | Charles River Laboratories International (1100682) Issuer Parisotto Shannon M (1952784) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/08/2026 3:21 PM | Charles River Laboratories International (1100682) Issuer Girshick Birgit (1732091) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/03/2026 8:45 PM | Barg Steven (1852883) Reporting Charles River Laboratories International (1100682) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/02/2026 3:46 PM | Charles River Laboratories International (1100682) Issuer Coleman Glenn (1434369) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/02/2026 3:27 PM | Charles River Laboratories International (1100682) Issuer Creamer Victoria L (1632780) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/02/2026 3:35 PM | Charles River Laboratories International (1100682) Issuer Girshick Birgit (1732091) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/28/2026 3:43 PM | Charles River Laboratories International (1100682) Issuer Creamer Victoria L (1632780) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/28/2026 3:33 PM | Charles River Laboratories International (1100682) Issuer Girshick Birgit (1732091) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/28/2026 3:36 PM | Charles River Laboratories International (1100682) Issuer Mintz Mark (2071546) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/14/2026 4:11 PM | Andrews Nancy C (1804999) Reporting Charles River Laboratories International (1100682) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/12/2026 4:14 PM | Barg Steven (1852883) Reporting Charles River Laboratories International (1100682) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/12/2026 3:19 PM | Charles River Laboratories International (1100682) Issuer Graves Paul W (1559551) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/12/2026 3:22 PM | Charles River Laboratories International (1100682) Issuer Thompson Craig B. (1423419) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/11/2026 4:01 PM | Charles River Laboratories International (1100682) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/11/2026 3:45 PM | Andrews Nancy C (1804999) Reporting Charles River Laboratories International (1100682) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/11/2026 3:48 PM | Charles River Laboratories International (1100682) Issuer MACKAY MARTIN (1414815) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/11/2026 3:51 PM | Ceesay Abraham (1722140) Reporting Charles River Laboratories International (1100682) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/11/2026 3:30 PM | Charles River Laboratories International (1100682) Issuer Kemps-Polanco Reshema (2009357) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/11/2026 3:32 PM | Charles River Laboratories International (1100682) Issuer Enyedy Mark J (1586965) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/11/2026 3:35 PM | Charles River Laboratories International (1100682) Issuer Llado George Sr. (1829162) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Bezos… DOOMED (Ad) A single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X combined - aimed at the $25 trillion AI industry.
James Altucher says the plan could cut Amazon out of the AI race and disrupt Blue Origin, with a key deadline landing September 25. Watch James Altucher's free video breakdown before the September 25 deadline. |
| 05/07/2026 3:56 PM | Charles River Laboratories International (1100682) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 05/07/2026 6:14 AM | Charles River Laboratories International (1100682) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/06/2026 2:45 PM | Charles River Laboratories International (1100682) Subject Invesco Ltd. (914208) Filed by | Form SCHEDULE 13G/A | |
| 05/06/2026 10:06 AM | Charles River Laboratories International (1100682) Subject FMR LLC (315066) Filed by | Form SCHEDULE 13G | |
| 05/04/2026 4:16 PM | Charles River Laboratories International (1100682) Issuer Coleman Glenn (1434369) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/29/2026 4:49 PM | Charles River Laboratories International (1100682) Subject VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by | Form SCHEDULE 13G | |
| 04/08/2026 3:53 PM | Charles River Laboratories International (1100682) Issuer Coleman Glenn (1434369) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/31/2026 6:50 AM | Charles River Laboratories International (1100682) Filer | Form DEF 14A | |
| 03/31/2026 6:54 AM | Charles River Laboratories International (1100682) Filer | Form ARS | |
| 03/26/2026 4:15 PM | Charles River Laboratories International (1100682) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 03/05/2026 4:18 PM | Charles River Laboratories International (1100682) Issuer Girshick Birgit (1732091) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/04/2026 3:39 PM | Charles River Laboratories International (1100682) Issuer LaPlume Joseph W (1767215) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/04/2026 3:42 PM | Charles River Laboratories International (1100682) Issuer FOSTER JAMES C (1141722) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/25/2026 6:34 AM | Charles River Laboratories International (1100682) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/18/2026 3:39 PM | Charles River Laboratories International (1100682) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/18/2026 8:21 AM | Charles River Laboratories International (1100682) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 02/18/2026 6:13 AM | Charles River Laboratories International (1100682) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/12/2026 12:51 PM | Charles River Laboratories International (1100682) Subject Invesco Ltd. (914208) Filed by | Form SCHEDULE 13G | |
| 02/10/2026 10:19 AM | Charles River Laboratories International (1100682) Subject | Form SCHEDULE 13G/A | |
| 02/03/2026 3:36 PM | Charles River Laboratories International (1100682) Issuer LaPlume Joseph W (1767215) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/02/2026 3:39 PM | Charles River Laboratories International (1100682) Issuer Knell Michael Gunnar (1543779) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/02/2026 3:42 PM | Charles River Laboratories International (1100682) Issuer Girshick Birgit (1732091) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/02/2026 3:46 PM | Charles River Laboratories International (1100682) Issuer FOSTER JAMES C (1141722) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/20/2026 7:49 AM | Charles River Laboratories International (1100682) Issuer LaPlume Joseph W (1767215) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/13/2026 7:10 AM | Charles River Laboratories International (1100682) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/09/2026 3:18 PM | Charles River Laboratories International (1100682) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/03/2025 6:28 AM | Charles River Laboratories International (1100682) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/17/2025 7:06 AM | Charles River Laboratories International (1100682) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/12/2025 8:33 AM | Charles River Laboratories International (1100682) Subject WELLINGTON MANAGEMENT GROUP LLP (902219) Filed by | Form SCHEDULE 13G/A | |
| 11/07/2025 3:35 PM | Charles River Laboratories International (1100682) Issuer Knell Michael Gunnar (1543779) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/05/2025 8:12 AM | Charles River Laboratories International (1100682) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/05/2025 6:16 AM | Charles River Laboratories International (1100682) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/19/2025 3:14 PM | Charles River Laboratories International (1100682) Filer | Form 8-K/A | |
| 09/16/2025 6:10 AM | Charles River Laboratories International (1100682) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |